Cancer Weekly

Colorectal Cancer - Drug that cuts off a tumor's blood supply shows promise

Epidemiology - U.K. cancer cases on the rise - but deaths are down

Glioblastoma Multiforme - Company provides update on IL13-PE38 development program

Glioblastoma Multiforme - IL-4 Fusion Toxin (NBI-3001) results reported

Hepatitis B Genetics - Mutations differentiate chronic infection and liver cancer in children

Hepatocellular Carcinoma - Serum endostatin predicts tumor vascularity

Leukemia - ANDA approvals in 2002 will lead to four launches in 2003

Leukemia - G-CSF-primed haploidentical marrow grafts feasible, effective for high-risk patients

Liver Cancer Therapy - New imaging technique improves guidance in percutaneous ablation therapy

Lung Cancer - INDA submitted for Tc-99m Hynic-Annexin V

Lung Cancer - Mount Sinai Comprehensive Cancer Center studies drug regimens

Malignant Glioma - Positive interim safety results reported from Reolysin phase I study

Melanoma - FcgammaR-positive tumors may respond to antibody-mediated therapies

Menopause - Combination hormone therapy associated with increase in breast density

Menopause - SERMs offer safer alternative than HRT

Mesothelioma - Asbestos-cancer treatments expected to improve

Monoclonal Antibodies - IND filed for therapeutic antibody

Multiple Myeloma - Degree of bone marrow angiogenesis is a prognostic marker

Non-Hodgkin lymphoma - FDA panel supports efficacy of Bexxar in rituximab-refractory patients

Non-Small Cell Lung Cancer - Phase III SMART trial of Xcytrin begins

Nutrition - Vitamin E, other nutrients may be tailored in future to target results

Ovarian Cancer - Yale clinical trial tests new treatment approach

Pain Medicine - Substantial improvements in cancer trials not likely caused by placebo effects

Pancreatic Cancer - New data reported from phase II trial of ISIS 2503 plus chemotherapy

Pleural Mesothelioma - Exposure to contaminated poliovirus vaccine not likely linked to rare cancer

Prostate Cancer - Estimating number of radiotherapy patients can prevent staffing shortages

Prostate Cancer - FDA panel requests more data on Casodex

Prostate Cancer - Novel approach shows promise for a blood test

Prostate Cancer - Rights regained to ex vivo prostate cancer immunotherapy

Prostate Cancer - Update provided on KRX-123

Renal Cell Carcinoma - Autologous monocyte-derived dendritic cell-based immunotherapy well tolerated

Skin Cancer - Broad-spectrum ultraviolet radiation added to list of known carcinogens

Transplant Medicine - Organ retention issue deals blow to children's cancer research

Tumors - MDA-7 activates immune system, has antiangiogenic properties

Tumors - Studies show that INGN 241 activates immune system